By Kayon Raynor
Olympic sprint relay gold medallist Nesta Carter is getting ready to fight a second anti-doping offence after testing positive for a banned substance recently.
Radio Jamaica Sports has confirmed that the hearing, to be handled by the Kent Gammon chaired three member Independent anti-doping disciplinary panel, is set to begin on Thursday, October 14.
When contacted on Tuesday, Gammon confirmed that matter involving the 2013 world 100m bronze medallist had been referred to his panel by the Jamaica Anti-Doping Commission.
“We have a matter with Nesta Carter… We do have a disciplinary hearing that was referred to me by JADCO,” Gammon told Radio Jamaica Sports, adding that the anti-doping ruling violation pertained to a positive test.
Gammon added that he along with Dr. Japheth Ford and Mr. Heron Dale will hear the matter virtually due to the challenges caused by the coronavirus.
Attorney Stuart Stimpson, who confirmed he will again be representing Carter, declined to provide any details on the substance or circumstances of the positive test by his client.
This latest anti-doping violation comes three years after the now retired sprinter lost his appeal at the Court of Arbitration for Sports (CAS) against the decision by the International Olympic Committee (IOC) to strip him and Jamaica's men's sprint relay team of their gold medal from the 2008 Beijing Olympics.
He had tested positive for the banned drug, Methylhexaneamine, retroactively from the 2008 Olympics.
In August, 35-year-old Carter revealed via a press release that he had retired due to a private medical condition.
At the time, Carter said the condition has been getting worse and has hindered him from training and competing since March 2021.
He said a medication prescribed by his doctor to treat the condition violates anti-doping rules and as such he has chosen his health over athletics.
Carter has a personal best of 9.78 seconds for the 100 metres, which ranks as the ninth fastest time ever and fourth best for a Jamaican sprinter.